+++if Bavi is all that we believe, the SP and market cap should be well north of where we are.
I agree. Logic dictates everything your gut is telling you. Any number of BP’s should have made an offer to partner or merge long… long ago. Since this isn’t the case, either:
1) King’s demands/expectations are beyond unreasonable in these half decade long “talks” or
2) Based on BP’s due diligence, they simply aren’t convinced that “value” is there yet to make a move.
Expecting that Peregrine is going to enroll 600 patients in the phase 3 study in 24 months is wishful thinking with the company’s lack of promotion and “believability”… We needed a CEO with a proven track record of “delivering” to have been promoting Bavi A/C for a long time….The fact is, King’s n’th dog and pony shows are proven to be of little value. The information is nice, no doubt, but the well documented track record of seldom meeting expectations and self-imposed deadlines is proving to be a hindrance in how the overall message is received.
I remember the regulars on this board jumping for joy about the “potential” of the imaging trial….have we even enrolled 5 people in 2 years yet? Again, lack of enthusiasm being fostered by the person delivering the message is materially impacting the programs in a negative way not to mention the share price at which the dilution is occurring that ultimately crushes the upside potential of longtime shareholders. Like it or not, these downstream impacts are the direct result of talking and not doing over a long period of time. It is almost March, and the liver trail can’t even complete enrolling when it has been described that almost nothing can be combined with the SOC effectively. Can anyone offer a valid reason why enrollment timeframe would be so disappointing? The pages on the calendar keep blowing by while the dilution machine keeps running and the progress keeps crawling. I believe that this “go it alone” strategy has been a disaster as it relates to a variety of other trials that should be funded but haven’t been over the last half decade. Let’s hop in a time machine and go back to the time when the Georgia and India phase 2 trials concluded. Had we partnered then….even resulting in a vanilla deal, the program would have been way further along by now and the long-term shareholders would have been way better off and could imagine a market cap in the billions by now with a late stage breast cancer trial hitting on all cylinders.
Someone posted earlier that Bavi will succeed in spite of the CEO…I concur. Unfortunately, at this rate we may be very well be facing yet another negative variable whereby Bavi succeeds and while the shareholders….were “right”, may just miss out on financially benefitting in the event a currency crisis takes place before this endeavor is “monetized”.
Let’s hope that something positive transpires real soon. I have to believe this new hire assisting King knows how to play this game, my only concern is King going overboard playing hard-ass with what otherwise would be deemed to be fair offers from potential suitors.
All IMHO
